[Biobanks]

(Biobanken.)

Full Abstract

Biobanks are an important tool of genetic epidemiology, which investigates the role of genetic factors and their interaction with environmental factors (in a broad meaning) for the occurrence of diseases in human populations. Its aim is to understand the influence of genetics on the development of diseases, their course and the clinical implications, with the final goal to improve prevention, diagnostics and therapy. The extraordinary development of genetics in the last decades - with respect to the understanding of the meaning of genes for human health, as well as the availability of cost-effective high throughput methods in the lab, has opened enormous opportunities to study genetic factors. In addition, access to large samples of patients or from the population is needed. This can be realized via biobanks. Large biobanks with 500,000 or more participants are being established or planned in the UK, Japan, Australia, Sweden and the US. However, in Germany only two smaller activities are ongoing, KORA-gen in the south and POPGEN in the north. Possibilities to reach larger numbers for Germany, based on existing cohorts or disease networks, are discussed. For the implementation and use of biobanks, stringent ethical boundary conditions have to be taken into account. The opinion of the German National Ethics Council on Biobanks for Research as well as the new recommendations of the Telematic Platform (TMF), which has been developed in close collaboration with the Data Protection Officers, improve transparency and legal security.

Learn Faster Today Improve your study skills

Author information

Author/s: Wichmann, H-E (HE); Gieger, C (C);

Affiliation: GSF Institut für Epidemiologie, Neuherberg, BRD. wichmann(-atsign-)gsf.de

Journal and publication information

Publication Type: English Abstract; Journal Article

Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz (Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz), published in Germany. (Language: ger)

Reference: 2007-Feb; vol 50 (issue 2) : pp 192-9

Dates: Created 2007/02/13; Completed 2007/05/02;

PMID: 17285353, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Databases, Genetic
Environmental Exposure - adverse effects
Genetic Diseases, Inborn - genetics
Genetic Privacy
Genetic Research

These are the highest related articles currently in the database:

Disclosure of genetic information obtained through research. 30 Dec 2003
Approaches to identify genes for complex human diseases: lessons from Mendelian disorders. 29 Sep 2003
DNA, diseases and databases: disastrously deficient. 30 May 2005
GFINDer: genetic disease and phenotype location statistical analysis and mining of dynamically annotated gene lists. 29 Jun 2005
Genotype-phenotype correlations in hereditary muscle diseases. Implications for diagnosis and treatment. 30 Dec 2003
Metabolomic approaches to phenotype characterization and applications to complex diseases. 29 Jun 2006
[The National Genome Research Network. Genome research in Germany] 30 Jan 2007
[Human genetic data from a data protection law perspective] 30 Jan 2007
What to call a syndrome. 13 May 2007
Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. 5 Jun 2007

See 100+ related articles.